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INTRODUCTION
  Sickle cell disease constitute one of the
most frequent occurring hereditary conditions in the
world. The disease is believed to have originated in
Africa, thousands of years ago and most of the
people afflicted today are African. It also occurs in
areas where malaria has at one time been quite
prevalent (Parveen and Michael, 1990).
Sickle cell disease is a genetic disease that
occur as a result of a change in the sequence for
the codon 6 of the β-chain from GAG in the normal
gene to GTG in the sickle cell genes resulting in
the substitution of valine for glutamic acid thereby
producing a sickle shaped red blood cell (Lorraine
and Sergeant, 2001).
The clinical signs and symptoms of sickle
cell disease usually do not appear until after the
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ABSTRACT
Some blood chemical parameters including some enzyme activities were determined in forty
two sickle cell patients in Ekiti state, Nigeria. All the parameters of interest analyzed for were found
present in all the samples. The mean values for uric acid (0.35±0.16mol/l), creatinine (100.55±8.13µmol/
l), urea (10.50±6.28mmol/l), Total bilirubin (14.42±2.03µmol/l), conjugated bilirubin (10.53±2.67µmol/
l), alkaline phosphatase (82.67±10.87µ/l) aspartate transaminase (SGOT) (20.68±9.85µ/l) and alanine
transaminase (SGPT) (28.68±9.85µ/L) were significantly higher (P<0.05) in sickle cell patients than
the control. Serum sodium (Na+) (110.00±4.0lmmol/L), potassium (K+) (2.56±0.63mmol/L) total protein
(60.05±10.35g/L), albumin (30.16±3.28g/L), Calcium (2.00±0.1mmol/L) and inorganic phosphate
(1.12±0.19mmol/L) were also found to be significantly lowered in sickle cell patient when compared
with the control. Analysis of the results showed an increase in plasma chloride (99.33±2.54mmol/L)
and decrease in bicarbonate (22.99±2.06mmol/L). The differences were however not statistically
significant (P>0.05). The significant raised level of SGPT, SGOT, ALP, total bilirubin, conjugated bilirubin,
and significant lower levels of total protein, albumin, calcium, inorganic phosphate indicates that there
may be abnormal liver and renal function as well as muscular and bone dysfunction in these patients.
Key words: Sickle cell, renal function and dysfunction.
sixth month of life at which time most of the HbF
(foetal haemoglobin) has been replaced by sickle
cell haemoglobin. Among the constitutional
manifestation of sickle cell diseases are impairment
of growth and development and a general failure to
thrive (Robert et.al.1999).
The increased morbidity and mortality of
sickle cell disease most especially in Ekiti State has
prompted the current research work. In view of
these, the present study reports some blood
chemistry parameters of sickle cell patient in Ekiti
State, Nigeria.
MATERIAL AND METHODS
Forty two sickle cell patients (30 females
and 12 males) aged between 12 and 30 years and
aged matched healthy people as control were used
for the study. The controls had no clinical evidence
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of sickle cell disease or other forms of diseases. All
patients were attending clinics at the Ekiti State
Specialist Hospital, (ESSH), Ado-Ekiti, Ekiti State,
Nigeria.
6mls of venous blood were collected from
each of the patients and the following parameters
were analysed: sodium (Na+), and potassium (K+),
were estimated using flame photometry techniques
using Gallenkamp flame photometer (AOAC, 1990),
chloride was determined by mercurimetric titration
method (Schales and Schales, 1941), while
bicarbonate was analysed using tr itr imetric
method (Henry et.al., 1974). Total and conjugated
bilirubin were estimated by Jendrassik and
Grof method (Tietz, 1986a), total protein
determination was carried out using Biuret method
described by (Peters and Doumas, 1982), albumin
estimation was performed using Bromocresol Green
(BCG) method of (Parveen and Michael, 1990 );
calcium was analysed by the O-cresolpthalein
complexone method described by (Lorentz, 1982),
inorganic phosphate determination was done by the
monophosmolybdate method described by (Tietz,
1986b). Aspartate transaminase (SOPT) and
alanine transaminase (SGPT) activities were
determined by the method described by (Tietz,
1986c) and alkaline phosphatase was assayed
using the method described by (Tietz and Rinker,
1986).
Statistical analysis
Results were expressed as mean +
standard deviation. The results were also analysed
by using the student’s ‘t’ test.
RESULTS
The table below presents Mean and
Standard deviations of sodium (Na+), potassium
(K+), chloride, (Cl-), bicarbonate (H2CO-3), total
bilirubin, total protein, albumin, calcium, inorganic
phosphate, aspartate transaminase, (AST), alanine
transaminase (ALT), and alkaline phosphate (ALP)
of sickle cell patient and healthy controls.
Parameters Sickle cell Patients Controls
Sodium (Na+) (mmol/L) 110±4.01 128±2.50
Potassium (K+) (mmol/L) 2.56±0.63 4.01±0.23
Chloride (Cl-) (mmol/L) 99.33±2.54 98.47±2.79
Bicarbonate (H2CO-3)(mmol/L) 22.99±2.06 23.92±1.03
Total bilirubin (µmol/L) 14.42±2.03 6.90±1.26
Conjugated bilirubin (µmol/L) 10.53±16.67 2.70±1.17
Plasma Total protein (g/L) 60.05±10.35 66.06±4.30
Plasma Albumin (g/L) 30.16±3.28 50.15±2.20
Calcium (mmol/L) 2.00±0.14 2.58±0.02
Serum Inorganic phosphate (mmol/L) 1.42±0.19 1.42±0.09
Aspartate transaminase (SGOT) (µ/L) 20.42±10.94 7.28±2.91
Alanine transaminase (SGPT) (µ/L) 28.68±9.85 10.94±3.31
Alkaline phosphatase (µ/L) 82.67±10.87 62.00±2.00
Urea (mmol/L) 10.50±6.28 5.50±2.10
Uric acid (mmol/L) 0.35±0.16 0.14±0.03
Creatinine (ìmol/L) 100.55±8.13 80.15±1.11
DISCUSSION
The results obtained from this study
showed that mean serum concentration of
potassium (K+) and sodium (Na+) were significantly
decreased (P<0.05) in sickle cell patients when
compared with the values obtained for the controls.
This was is agreement with the work of (Redal, et,al.,
2001) who reported severe hyponatraemia in sickle
cell disease. This decrease observed in the
potassium and sodium levels in sickle cell patients
might be due to increased urinary excretion of these
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electrolytes and hypo-osmolality, since majority of
these patient exhibit a salt wasting state and
increased secretion of antidiuretic hormone most
especially during crisis (Wilson and Alleyne, 2000).
The results show that the values of chloride
and bicarbonate of sickle cell patients were not
significantly different from their aged-matched
healthy peers. This is indicative of absence of
substance of acidosis. Total bilirubin and conjugated
bilirubin were significantly raised (P<0.05) in sickle
cell patients. These results support the report of
higher total and conjugated bilirubin concentration
(Lester and Schmid 2004) in sickle cell patient. This
increase in total and conjugated bilirubin in sickle
cell patient might be due to increased breakdown
of red blood cells. The significantly lower levels of
total protein and albumin indicates that the liver is
damaged, therefore is not synthesizing normally.
This compares favourably with the work of
(Maclagan, 1999).
The mean serum transaminases (SGOT
and SGPT) activities were found to be significant
higher (P<0.05) in sickle cell patient. This increase
might be due to the leakage of these enzymes from
the cytoplasm and mitochondria of the liver tissue
following hepatic injury which is common in sickle
cell anaemia. (Latner and Skitten, 2002). The mean
activity of Alkaline phosphatase (ALP) was also
found to be significantly higher (P<0.05) in sickle
cell patient than in normal subjects. This result
supports the report of (Fishman, 2004). The
increase in activity of ALP could be due to increased
released of this enzyme from bone marrows and
liver hepatocytes, hence, the weakness of the bones
seen in sickle cell patients.
Calcium concentration was found to be
significantly lower (P<0.05) in sickle cell patients
than in normal controls. This supports the report
of (Palek, 2003). This decrease in plasma calcium
in sickle cel l  patients might be due to
accumulation of calcium ions in the cell rather
than in the blood. The plasma inorganic
phosphate was found to be significantly lowered
in sickle cell patients than in normal subjects. This
increase might be due to increase in ALP
activity. The plasma concentrations of urea and
creatinine were significantly higher (P<0.05) in
sickle cell patient than in the control, this might
be due to excess body protein catabolism and
muscular wasting respectively. Uric acid was also
found to be significantly raised. This supports the
findings of (Roswe, 2000). This indicates that
there are abnormal renal and probably
endocrinological processes supporting the sickled
cell seen in these patients. The kidney tubules
may have been damaged by excessive hormonal
action of parathormone and vitamin D which may
be acting in excessively compensatory amount
to maintain normal plasma calcium and
phosphate levels.
In general, the results, obtained from this
study indicates liver and renal dysfuction in these
patients as well as problem with bone metabolism.
These results will serve as baseline data
for the clinicians in treating sickle cell diseases. For
instance, hypertonic fluids can be administered to
the patients and diet rich in protein and calcium
can be recommended to complement treatment
most especially during crisis.
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